Weak complex formation of adverse drug reaction-associated HLA B57, B58, and B15 molecules

Saved in:
Bibliographic Details
Published inToxicology in vitro Vol. 82; p. 105383
Main Authors Shirayanagi, Tomohiro, Kazaoka, Akira, Watanabe, Kenji, Qu, Liang, Sakamoto, Naoki, Hoshino, Tyuji, Ito, Kousei, Aoki, Shigeki
Format Journal Article
LanguageEnglish
Published 01.08.2022
Online AccessGet full text

Cover

ArticleNumber 105383
Author Shirayanagi, Tomohiro
Kazaoka, Akira
Sakamoto, Naoki
Hoshino, Tyuji
Watanabe, Kenji
Ito, Kousei
Qu, Liang
Aoki, Shigeki
Author_xml – sequence: 1
  givenname: Tomohiro
  surname: Shirayanagi
  fullname: Shirayanagi, Tomohiro
– sequence: 2
  givenname: Akira
  surname: Kazaoka
  fullname: Kazaoka, Akira
– sequence: 3
  givenname: Kenji
  surname: Watanabe
  fullname: Watanabe, Kenji
– sequence: 4
  givenname: Liang
  surname: Qu
  fullname: Qu, Liang
– sequence: 5
  givenname: Naoki
  surname: Sakamoto
  fullname: Sakamoto, Naoki
– sequence: 6
  givenname: Tyuji
  surname: Hoshino
  fullname: Hoshino, Tyuji
– sequence: 7
  givenname: Kousei
  surname: Ito
  fullname: Ito, Kousei
– sequence: 8
  givenname: Shigeki
  surname: Aoki
  fullname: Aoki, Shigeki
BookMark eNotkLFOwzAYhD0UibbwAGx-gKb8jmPHGdsKKFIlFhASi-XYf1BCEld2WsHbk6gd7k6nk274FmTW-x4JeWCwZsDkY7Me6vM6hTQdu-CKz8gclMqTlHN-SxYxNgAgVApz8vWJ5oda3x1b_KWVD50Zat9TX1HjzhgiUhdO3zSgsdOQmBi9rc2Aju4PG7oV-Wo0taKmd3TLBO18i_bUYrwjN5VpI95fc0k-np_ed_vk8PbyutscEstFNiSlsDnILC9MDlCigDIrKmQMU5Y5gVKAta5gJSskSq4yKzko5kCMKqTifEnY5dcGH2PASh9D3ZnwpxnoCYhu9AhET0D0BQj_BxReVlE
CitedBy_id crossref_primary_10_1248_bpb_b24_00072
crossref_primary_10_1093_pnasnexus_pgae140
Cites_doi 10.1074/jbc.M605492200
10.1093/rheumatology/kev296
10.1002/art.24599
10.3109/09273948.2011.634978
10.1073/pnas.0307067101
10.1002/cpt.683
10.5415/apallergy.2016.6.2.77
10.1042/bj2770359
10.4049/jimmunol.1301670
10.1186/1750-1172-6-52
10.1038/s42003-021-02657-2
10.1093/jb/mvi057
10.1038/428486a
10.1111/all.13821
10.1016/j.seizure.2010.11.014
10.1097/QAD.0b013e3280119579
10.1007/s00204-017-2112-9
10.1248/bpb.b20-00102
10.1038/nature11147
10.1097/FPC.0000000000000153
10.1073/pnas.1207934109
10.1086/529382
10.1038/s41467-018-07109-w
10.1016/S1734-1140(13)71483-X
10.1021/ct400341p
10.1093/database/baw069
10.1074/jbc.M111.237784
10.1097/QAI.0b013e31827ca50f
10.1016/S0079-6603(08)60034-3
10.1097/QAD.0000000000002519
10.1038/srep45553
10.1002/art.39567
10.1002/eji.201445307
10.1146/annurev-immunol-032712-095910
10.1038/ng.379
10.1172/JCI99321
10.1371/journal.pone.0095339
10.2217/pgs.09.162
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1016/j.tiv.2022.105383
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Public Health
Pharmacy, Therapeutics, & Pharmacology
ExternalDocumentID 10_1016_j_tiv_2022_105383
GroupedDBID ---
--K
--M
.~1
0R~
123
1B1
1RT
1~.
1~5
29Q
4.4
457
4G.
53G
5VS
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXKI
AAXUO
AAYXX
ABFRF
ABFYP
ABJNI
ABLST
ABMAC
ABXDB
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AFJKZ
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHEUO
AHHHB
AIEXJ
AIKHN
AITUG
AJOXV
AKIFW
AKRWK
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLECG
BLXMC
CITATION
CS3
DU5
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMT
HVGLF
HZ~
IHE
J1W
KCYFY
KOM
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SDF
SDG
SDP
SES
SEW
SPCBC
SPT
SSJ
SSP
SSZ
T5K
UNMZH
WUQ
ZXP
~G-
ID FETCH-LOGICAL-c354t-b5c706479a700be50b49fe11e214d5e650ccd91b196e6384c63081d051d096833
ISSN 0887-2333
IngestDate Thu Sep 26 17:47:58 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c354t-b5c706479a700be50b49fe11e214d5e650ccd91b196e6384c63081d051d096833
OpenAccessLink http://manuscript.elsevier.com/S0887233322000807/pdf/S0887233322000807.pdf
ParticipantIDs crossref_primary_10_1016_j_tiv_2022_105383
PublicationCentury 2000
PublicationDate 2022-08-00
PublicationDateYYYYMMDD 2022-08-01
PublicationDate_xml – month: 08
  year: 2022
  text: 2022-08-00
PublicationDecade 2020
PublicationTitle Toxicology in vitro
PublicationYear 2022
References Jaruthamsophon (10.1016/j.tiv.2022.105383_bb0090) 2017; p. 7
Loll (10.1016/j.tiv.2022.105383_bb0100) 2016; 68
Génin (10.1016/j.tiv.2022.105383_bb0045) 2011; 6
Hung (10.1016/j.tiv.2022.105383_bb0075) 2010; 11
Daly (10.1016/j.tiv.2022.105383_bb0040) 2009; 41
Taurog (10.1016/j.tiv.2022.105383_bb0180) 2009; 60
Adam (10.1016/j.tiv.2022.105383_bb0010) 2014; 9
He (10.1016/j.tiv.2022.105383_bb0060) 2013; 65
Blum (10.1016/j.tiv.2022.105383_bb0020) 2013; 31
Brostrom (10.1016/j.tiv.2022.105383_bb0025) 1998; 58
Shirayanagi (10.1016/j.tiv.2022.105383_bb0165) 2020; 43
Queiro (10.1016/j.tiv.2022.105383_bb0145) 2016; 55
Morishima (10.1016/j.tiv.2022.105383_bb0120) 2005; 137
Ostrov (10.1016/j.tiv.2022.105383_bb0125) 2012; 109
Kongpan (10.1016/j.tiv.2022.105383_bb0095) 2015; 25
Susukida (10.1016/j.tiv.2022.105383_bb0175) 2021; 4
Gul (10.1016/j.tiv.2022.105383_bb0055) 2012; 20
Martin (10.1016/j.tiv.2022.105383_bb0110) 2007; 21
Phillips (10.1016/j.tiv.2022.105383_bb0140) 2013; 62
Mockenhaupt (10.1016/j.tiv.2022.105383_bb0115) 2019; 74
Perria (10.1016/j.tiv.2022.105383_bb0135) 2006; 281
Susukida (10.1016/j.tiv.2022.105383_bb0170) 2018; 92
Wu (10.1016/j.tiv.2022.105383_bb0195) 2020; 7
Saag (10.1016/j.tiv.2022.105383_bb0160) 2008; 46
Abualrous (10.1016/j.tiv.2022.105383_bb0005) 2015; 45
Martin (10.1016/j.tiv.2022.105383_bb0105) 2004; 101
Adeeb (10.1016/j.tiv.2022.105383_bb0015) 2017; 35
Chung (10.1016/j.tiv.2022.105383_bb0035) 2004; 428
Tsai (10.1016/j.tiv.2022.105383_bb0185) 2002; 29
Hu (10.1016/j.tiv.2022.105383_bb0070) 2011; 20
Ghattaoraya (10.1016/j.tiv.2022.105383_bb0050) 2016; 2016
Illing (10.1016/j.tiv.2022.105383_bb0080) 2012; 486
Yun (10.1016/j.tiv.2022.105383_bb0205) 2016; 6
Hentzien (10.1016/j.tiv.2022.105383_bb0065) 2020; 34
Pan (10.1016/j.tiv.2022.105383_bb0130) 2017; 102
Tysoe-Calnon (10.1016/j.tiv.2022.105383_bb0190) 1991; 277
Wycisk (10.1016/j.tiv.2022.105383_bb0200) 2011; 286
Illing (10.1016/j.tiv.2022.105383_bb0085) 2018; 9
Rizvi (10.1016/j.tiv.2022.105383_bb0150) 2014; 192
Roe (10.1016/j.tiv.2022.105383_bb0155) 2013; 9
Cardone (10.1016/j.tiv.2022.105383_bb0030) 2018; 128
References_xml – volume: 281
  start-page: 39839
  year: 2006
  ident: 10.1016/j.tiv.2022.105383_bb0135
  article-title: Catalytic site modifications of TAP1 and TAP2 and their functional consequences
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M605492200
  contributor:
    fullname: Perria
– volume: 55
  start-page: 221
  year: 2016
  ident: 10.1016/j.tiv.2022.105383_bb0145
  article-title: HLA-B27 and psoriatic disease: a modern view of an old relationship
  publication-title: Rheumatol. (Oxf. Engl.).
  doi: 10.1093/rheumatology/kev296
  contributor:
    fullname: Queiro
– volume: 60
  start-page: 1977
  year: 2009
  ident: 10.1016/j.tiv.2022.105383_bb0180
  article-title: Spondylarthritis in HLA-B27/human beta2-microglobulin-transgenic rats is not prevented by lack of CD8
  publication-title: Arthritis Rheum.
  doi: 10.1002/art.24599
  contributor:
    fullname: Taurog
– volume: 20
  start-page: 37
  year: 2012
  ident: 10.1016/j.tiv.2022.105383_bb0055
  article-title: HLA-B*51 and Behçet disease
  publication-title: Ocul. Immunol. Inflamm.
  doi: 10.3109/09273948.2011.634978
  contributor:
    fullname: Gul
– volume: 29
  start-page: 966
  year: 2002
  ident: 10.1016/j.tiv.2022.105383_bb0185
  article-title: Free HLA class I heavy chain-carrying monocytes--a potential role in the pathogenesis of spondyloarthropathies
  publication-title: J. Rheumatol.
  contributor:
    fullname: Tsai
– volume: 101
  start-page: 4180
  year: 2004
  ident: 10.1016/j.tiv.2022.105383_bb0105
  article-title: Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0307067101
  contributor:
    fullname: Martin
– volume: 102
  start-page: 86
  year: 2017
  ident: 10.1016/j.tiv.2022.105383_bb0130
  article-title: Pharmacogenomic advances in the prediction and prevention of cutaneous idiosyncratic drug reactions
  publication-title: Clin. Pharmacol. Ther.
  doi: 10.1002/cpt.683
  contributor:
    fullname: Pan
– volume: 6
  start-page: 77
  year: 2016
  ident: 10.1016/j.tiv.2022.105383_bb0205
  article-title: T-cell-mediated drug hypersensitivity: immune mechanisms and their clinical relevance
  publication-title: Asia Pac. Allergy.
  doi: 10.5415/apallergy.2016.6.2.77
  contributor:
    fullname: Yun
– volume: 277
  start-page: 359
  year: 1991
  ident: 10.1016/j.tiv.2022.105383_bb0190
  article-title: Molecular comparisons of the beta 2-microglobulin-binding site in class I major-histocompatibility-complex alpha-chains and proteins of related sequences
  publication-title: Biochem. J.
  doi: 10.1042/bj2770359
  contributor:
    fullname: Tysoe-Calnon
– volume: 192
  start-page: 4967
  year: 2014
  ident: 10.1016/j.tiv.2022.105383_bb0150
  article-title: Distinct assembly profiles of HLA-B molecules
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1301670
  contributor:
    fullname: Rizvi
– volume: 6
  start-page: 52
  year: 2011
  ident: 10.1016/j.tiv.2022.105383_bb0045
  article-title: Genome-wide association study of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe
  publication-title: Orphanet J. Rare Dis.
  doi: 10.1186/1750-1172-6-52
  contributor:
    fullname: Génin
– volume: 4
  start-page: 1137
  year: 2021
  ident: 10.1016/j.tiv.2022.105383_bb0175
  article-title: Regulation of the immune tolerance system determines the susceptibility to HLA-mediated abacavir-induced skin toxicity
  publication-title: Commun. Biol.
  doi: 10.1038/s42003-021-02657-2
  contributor:
    fullname: Susukida
– volume: 137
  start-page: 449
  year: 2005
  ident: 10.1016/j.tiv.2022.105383_bb0120
  article-title: Control of cell fate by Hsp70: more than an evanescent meeting
  publication-title: J. Biochem.
  doi: 10.1093/jb/mvi057
  contributor:
    fullname: Morishima
– volume: 428
  start-page: 486
  year: 2004
  ident: 10.1016/j.tiv.2022.105383_bb0035
  article-title: Medical genetics: A marker for Stevens–Johnson syndrome
  publication-title: Nature.
  doi: 10.1038/428486a
  contributor:
    fullname: Chung
– volume: 74
  start-page: 2227
  year: 2019
  ident: 10.1016/j.tiv.2022.105383_bb0115
  article-title: HLA-B*57:01 confers genetic susceptibility to carbamazepine-induced SJS/TEN in Europeans
  publication-title: Allergy.
  doi: 10.1111/all.13821
  contributor:
    fullname: Mockenhaupt
– volume: 20
  start-page: 160
  year: 2011
  ident: 10.1016/j.tiv.2022.105383_bb0070
  article-title: Pilot association study of oxcarbazepine-induced mild cutaneous adverse reactions with HLA-B*1502 allele in Chinese Han population
  publication-title: Seizure.
  doi: 10.1016/j.seizure.2010.11.014
  contributor:
    fullname: Hu
– volume: 21
  start-page: 1233
  year: 2007
  ident: 10.1016/j.tiv.2022.105383_bb0110
  article-title: Immune responses to abacavir in antigen-presenting cells from hypersensitive patients
  publication-title: AIDS.
  doi: 10.1097/QAD.0b013e3280119579
  contributor:
    fullname: Martin
– volume: 92
  start-page: 1177
  year: 2018
  ident: 10.1016/j.tiv.2022.105383_bb0170
  article-title: Evaluation of immune-mediated idiosyncratic drug toxicity using chimeric HLA transgenic mice
  publication-title: Arch. Toxicol.
  doi: 10.1007/s00204-017-2112-9
  contributor:
    fullname: Susukida
– volume: 43
  start-page: 1007
  year: 2020
  ident: 10.1016/j.tiv.2022.105383_bb0165
  article-title: Detection of Abacavir-induced structural alterations in human leukocyte antigen-B*57:01 using phage display
  publication-title: Biol. Pharm. Bull.
  doi: 10.1248/bpb.b20-00102
  contributor:
    fullname: Shirayanagi
– volume: 486
  start-page: 554
  year: 2012
  ident: 10.1016/j.tiv.2022.105383_bb0080
  article-title: Immune self-reactivity triggered by drug-modified HLA-peptide repertoire
  publication-title: Nature.
  doi: 10.1038/nature11147
  contributor:
    fullname: Illing
– volume: 25
  start-page: 402
  year: 2015
  ident: 10.1016/j.tiv.2022.105383_bb0095
  article-title: Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions
  publication-title: Pharmacogenet. Genomics
  doi: 10.1097/FPC.0000000000000153
  contributor:
    fullname: Kongpan
– volume: 109
  start-page: 9959
  year: 2012
  ident: 10.1016/j.tiv.2022.105383_bb0125
  article-title: Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1207934109
  contributor:
    fullname: Ostrov
– volume: 46
  start-page: 1111
  year: 2008
  ident: 10.1016/j.tiv.2022.105383_bb0160
  article-title: Study of hypersensitivity to a, Pharmacogenetic evaluation study T: high sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients
  publication-title: Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am.
  doi: 10.1086/529382
  contributor:
    fullname: Saag
– volume: 9
  start-page: 4693
  year: 2018
  ident: 10.1016/j.tiv.2022.105383_bb0085
  article-title: HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-07109-w
  contributor:
    fullname: Illing
– volume: 65
  start-page: 1256
  year: 2013
  ident: 10.1016/j.tiv.2022.105383_bb0060
  article-title: Association between the HLA-B*15:02 allele and carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Han individuals of northeastern China
  publication-title: Pharmacol. Rep.
  doi: 10.1016/S1734-1140(13)71483-X
  contributor:
    fullname: He
– volume: 9
  start-page: 3084
  year: 2013
  ident: 10.1016/j.tiv.2022.105383_bb0155
  article-title: PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data
  publication-title: J. Chem. Theor. Comput.
  doi: 10.1021/ct400341p
  contributor:
    fullname: Roe
– volume: 7
  year: 2020
  ident: 10.1016/j.tiv.2022.105383_bb0195
  article-title: The clinical characteristics of other HLA-B types in Chinese ankylosing spondylitis patients
  publication-title: Front. Med. (Lausanne).
  contributor:
    fullname: Wu
– volume: 2016
  year: 2016
  ident: 10.1016/j.tiv.2022.105383_bb0050
  article-title: A web resource for mining HLA associations with adverse drug reactions: HLA-ADR
  publication-title: Database. (Oxford)
  doi: 10.1093/database/baw069
  contributor:
    fullname: Ghattaoraya
– volume: 286
  start-page: 41402
  year: 2011
  ident: 10.1016/j.tiv.2022.105383_bb0200
  article-title: Epstein-Barr viral BNLF2a protein hijacks the tail-anchored protein insertion machinery to block antigen processing by the transport complex TAP
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M111.237784
  contributor:
    fullname: Wycisk
– volume: 35
  start-page: 22
  issue: Suppl. 104
  year: 2017
  ident: 10.1016/j.tiv.2022.105383_bb0015
  article-title: Associations of HLA-B alleles with Behçet's disease in Ireland
  publication-title: Clin. Exp. Rheumatol.
  contributor:
    fullname: Adeeb
– volume: 62
  start-page: e55
  year: 2013
  ident: 10.1016/j.tiv.2022.105383_bb0140
  article-title: Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa
  publication-title: J. Acquir. Immune Defic. Syndr.
  doi: 10.1097/QAI.0b013e31827ca50f
  contributor:
    fullname: Phillips
– volume: 58
  start-page: 79
  year: 1998
  ident: 10.1016/j.tiv.2022.105383_bb0025
  article-title: Regulation of translational initiation during cellular responses to stress
  publication-title: Prog. Nucleic Acid Res. Mol. Biol.
  doi: 10.1016/S0079-6603(08)60034-3
  contributor:
    fullname: Brostrom
– volume: 34
  start-page: 1057
  year: 2020
  ident: 10.1016/j.tiv.2022.105383_bb0065
  article-title: Factors associated with psoriasis in a French Nationwide HIV cohort: the independent role of HLA-B*57:01
  publication-title: AIDS.
  doi: 10.1097/QAD.0000000000002519
  contributor:
    fullname: Hentzien
– volume: p. 7
  start-page: 45553
  year: 2017
  ident: 10.1016/j.tiv.2022.105383_bb0090
  article-title: HLA-B*15:21 and carbamazepine-induced Stevens-Johnson syndrome: pooled-data and in silico analysis
  publication-title: Sci. Rep.
  doi: 10.1038/srep45553
  contributor:
    fullname: Jaruthamsophon
– volume: 68
  start-page: 1172
  year: 2016
  ident: 10.1016/j.tiv.2022.105383_bb0100
  article-title: Increased conformational flexibility of HLA-B*27 subtypes associated with ankylosing spondylitis
  publication-title: Arthritis Rheum.
  doi: 10.1002/art.39567
  contributor:
    fullname: Loll
– volume: 45
  start-page: 1248
  year: 2015
  ident: 10.1016/j.tiv.2022.105383_bb0005
  article-title: F pocket flexibility influences the tapasin dependence of two differentially disease-associated MHC Class I proteins
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.201445307
  contributor:
    fullname: Abualrous
– volume: 31
  start-page: 443
  year: 2013
  ident: 10.1016/j.tiv.2022.105383_bb0020
  article-title: Pathways of antigen processing
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev-immunol-032712-095910
  contributor:
    fullname: Blum
– volume: 41
  start-page: 816
  year: 2009
  ident: 10.1016/j.tiv.2022.105383_bb0040
  article-title: HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
  publication-title: Nat. Genet.
  doi: 10.1038/ng.379
  contributor:
    fullname: Daly
– volume: 128
  start-page: 2819
  year: 2018
  ident: 10.1016/j.tiv.2022.105383_bb0030
  article-title: A transgenic mouse model for HLA-B*57:01-linked abacavir drug tolerance and reactivity
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI99321
  contributor:
    fullname: Cardone
– volume: 9
  year: 2014
  ident: 10.1016/j.tiv.2022.105383_bb0010
  article-title: Abacavir induced T cell reactivity from drug Naïve individuals shares features of Allo-immune responses
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0095339
  contributor:
    fullname: Adam
– volume: 11
  start-page: 349
  year: 2010
  ident: 10.1016/j.tiv.2022.105383_bb0075
  article-title: Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese
  publication-title: Pharmacogenomics.
  doi: 10.2217/pgs.09.162
  contributor:
    fullname: Hung
SSID ssj0005820
Score 2.4018407
SourceID crossref
SourceType Aggregation Database
StartPage 105383
Title Weak complex formation of adverse drug reaction-associated HLA B57, B58, and B15 molecules
Volume 82
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYoHFqpQoW26ls-VBzIZrWJ8zwCAq2gRRwWFfUS2Y6h2RWbKg0IOPDb-zl2ki1QqfRiRY41ijJfxp8n8yDkM8v9UMhIuTxWyg3S08Tlyk9dJoSX-6nPudR-yK-H0fg42D8JT_qwsSa7pBZDefNgXsn_aBVz0KvOkn2EZjuhmMA19IsRGsb4Tzr-pvjMBIWrqz4N0f7aB69TTl5dnDnghU32gsutLkAyx1-2nG3dexfqDZM2hnPbC51z0zDXxhZa3joprwppyjUVc-eyqKuy8838KCp-3bQ7apRfnpeY6W4f8Btezoz3dlZU_S7AQUu5UDY5aFr0LljjK-B2T7UuCZxm24C4RcvlM1PhojWzpseQtZNgdcw0sLlnwo03YYod-3KohQ_7tX-Wy76zjXXBhW3c2jSDiEyLyIyIJ2TFhznSgX_D24VAoMQU72wfuv333UQB3nmKBfayQEMmL8iqPT_QLQOGNbKk5uvk6U7btm-dbByZYuTXAzrpc-t-DegGPerLlGPhc-OxpSYR7SX5rtFELZpohyZanlKLJqrRRB9AEwWaKNA0wJAMKJBEgSTaIekVOd7bneyMXdt5w5UsDGpXhDLWWcgpj0cjocKRwFesPE_5XpCHCqxeyjz1BMy3ggEPZMRALXMY-BxH4oSx12R5Xs7VG0LjmAvBk4gFQgbeKNINFZJUMAiIcZb235LN9o1mP02BleyvGnz3mMXvybMenB_Icl1dqI9gkLX41ADgN7cjbMc
link.rule.ids 315,783,787,27938,27939
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Weak+complex+formation+of+adverse+drug+reaction-associated+HLA+B57%2C+B58%2C+and+B15+molecules&rft.jtitle=Toxicology+in+vitro&rft.au=Shirayanagi%2C+Tomohiro&rft.au=Kazaoka%2C+Akira&rft.au=Watanabe%2C+Kenji&rft.au=Qu%2C+Liang&rft.date=2022-08-01&rft.issn=0887-2333&rft.volume=82&rft.spage=105383&rft_id=info:doi/10.1016%2Fj.tiv.2022.105383&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_tiv_2022_105383
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0887-2333&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0887-2333&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0887-2333&client=summon